technetium-99m diethylenetriaminepentaacetic acid-Andrey Petrov

Technetium-99m diethylenetriaminepentaacetic acid-Andrey Petrov refers to a specific radiopharmaceutical formulation of 99mTc-DTPA (technetium Tc 99m pentetate) used in clinical research sponsored by Andrey Petrov. This formulation is designed for inhalation via the Enhanced Digital Dose Inhalation Delivery System (EDDIS-IDDS) to evaluate lung deposition and device performance. It consists of 99mTc-DTPA in a 0.9% sodium chloride solution, combined with a non-labeled microdose of perfluorocarbon emulsion to simulate the aerodynamic behavior of therapeutic inhaled agents. As a gamma-emitting tracer, it allows for real-time scintigraphic imaging and digital validation of inspiratory parameters, such as volume, flow, and breath-hold duration, in healthy volunteers. The primary use in this context is as a diagnostic tool for pulmonary imaging and the validation of precision inhalation technology.

Brand names

An-DTPAMPI DTPADraximage DTPA

Other names

technetium-99m diethylenetriaminepentaacetic acidtechnetium99m diethylenetriaminepentaacetic acidtechnetium 99m diethylenetriaminepentaacetic acidtechnetium Tc 99m pentetateTc-99m DTPATc99m DTPATc 99m DTPA